KMB 한국미생물·생명공학회 e-생물산업 웹진은 다양하고 알찬 내용으로
여러분을 찾아갑니다.

2021 September Vol.34 No.3 ISSN 1598-8384

KMB 우수논문

이미지1

논문 요약

Continued growth in the probiotic market has resulted in a widening of the product range. This has results in both increased consumer expectations but also a tightening of regulatory measures. Defined to be live microorganisms, probiotics should provide a benefit to the host when consumed at a proper dose and in a viable state. Procedures for maintaining the shelf-life of probiotic cultures may damage the integrity of the cells due to stress conditions during both the freezing and (vacuum-) drying process, thereby negatively influencing their functionality. We propose a lysine-based mixture for rehydration of freeze-dried probiotics for improving their viability during in vitro simulated gastric and duodenum stress conditions. Measurement of the zeta potential served as an indicator of cell integrity and efficacy of this mixture, while functionality was estimated by adhesion to a human enterocyte-like Caco-2 cell-line. The freeze-dried bacteria exhibited a significantly different zeta potential compared to fresh cultures; however, this condition could be restored by rehydration with the lysine mixture. Recovery of the surface charge was found to influence adhesion ability to the Caco-2 cell-line. The lysine Zeta-bio formulation also notably increased the adherence ability of lyophilized Lp-115 to the Caco-2 cell-line after subjected to in vitro stress conditions simulating the gastrointestinal tract passage.

교신저자

Wilhelm Heinrich Holzapfel

Laboratory of Human Effective Microbes, Department of Advanced Convergence and HEM Pharma Inc., Business Incubator Center 103, Handong Global University
E-mail : wilhelm@woodapple.net

[약력]
  • 1966 – 1969

    Dr. rer. nat. at the Technical University of Munich, Germany

  • 1987 – 2007

    Former Head of the Federal Research Institute of Hygiene and Toxicology at the BFE, Karlsruhe, now Max Rubner Institute, Germany

  • 1996 – 2007

    Honorary Professor at Karlsruhe Technical University (KIT), Germany

  • 1996 – present

    President of the ICFMH of the IUMS

  • 1986 – present

    Member of IUMS Subcommittee on the Taxonomy of Bifidobacterium and Lactobacillus and related organisms

  • 2007 – 2013

    Full Professor at Handong Global University, South Korea

  • 2013 - present

    Chair Professor at Handong Global University, South Korea

  • Published papers

    >360 publications in scientific journals; >70 book chapters; editor of 8 scientific textbooks.

제1저자

Karina Arellano Ayala

Laboratory of Human Effective Microbes, Department of Advanced Convergence, Handong Global University
E-mail : karay.mx@gmail.com

[약력]
  • 2006 – 2010

    Bachelor’s Degree at University of Guadalajara, Mexico

  • 2013 – 2015

    Master’s in Sciences in Biotechnological Processes at University of Gudalajara, Mexico

  • 2016 – 2020

    Ph.D. in Microbiology at Advanced Convergence, Handong Global University, South Korea

  • 2012 – 2013

    Technical Assistant at BIOZOO S.A de C.V., Mexico

  • 2015 – 2016

    Technical Assistant at CIAJ Laboratory, Mexico

  • 2020 – present

    High School Teacher at Monterrey Institute of Technology and Higher Education, Mexico

  • Scientific papers

    8 publications in scientific journals

Haryung Park

HEM Pharma Inc., Business Incubator Center 103, Handong Global University
E-mail : hrpark@hempharma.bio

[약력]
  • 2010 – 2014

    Bachelor’s Degree at Handong Global University, South Korea

  • 2014 – 2016

    Master’s in Microbiology in Laboratory of Human Effective Microbes at Handong Global University, South Korea

  • 2016 – 2020

    Ph.D. in Microbiology in Laboratory of Human Effective Microbes at Handong Global University, South Korea

  • 2018 – Present

    Research Scientist at HEM Pharma Inc., South Korea

  • Scientific papers

    16 papers in scientific journals

연구실 소개

The Laboratory of Human Effective Microbes at Handong Global University together with HEM Pharma Inc. studies the modulatory effect of probiotics on the host, with special focus on the host microbiome in disease states such as obesity, diabetes, hypercholesterolemia, inflammatory bowel disease, asthma, and depression. HEM Pharma Inc. is a research-based bio-company, initiated as start-up at Handong Global University, that aims to provide a personalized therapeutic solution through investigating of the impact of our microbiome and its metabolites on our overall health.